Technical Analysis for LLY - Eli Lilly and Company

Grade Last Price % Change Price Change
B 196.21 0.65% 1.27
LLY closed up 0.65 percent on Friday, May 14, 2021, on 52 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical LLY trend table...

Date Alert Name Type % Chg
Overbought Stochastic Strength 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.65%
Outside Day Range Expansion 0.65%
Overbought Stochastic Strength 0.65%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.56%
Overbought Stochastic Strength 1.56%
Down 3 Days in a Row Weakness 1.56%
Stochastic Sell Signal Bearish 0.75%
Overbought Stochastic Strength 0.75%
Bearish Engulfing Bearish 0.74%
Older End-of-Day Signals for LLY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eli Lilly and Company Description

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; bipolar depression and treatment-resistant depression; and brain imaging of beta-amyloid plaques. Its endocrinology products treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. The company's oncology products treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as cardiovascular products, which are used treat erectile dysfunction, benign prostatic hyperplasia, high cholesterol, pulmonary arterial hypertension; reduce thrombotic cardiovascular events; and used as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; products to treat canine separation anxiety; products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections; and other pharmaceutical products to treat staphylococcal and bacterial infections. The company distributes its products through independent wholesale distributors; and directly to pharmacies. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Diabetes Pharmaceutical Products Neuroscience Hypertension Health Products Animal Health Antibiotic Mental Health Dysfunction Wholesale Distributor Schizophrenia Wholesale Distributors Dogs Milk Psychiatric Diagnosis Psychiatry Pulmonary Arterial Hypertension Bacterial Infections Cholesterol Major Depressive Disorder Antibiotics Cattle Depressive Disorder Amyloid Animal Health Products Depression Head And Neck Cancer Attention Deficit Hyperactivity Disorder Endocrinology Helio Hyperplasia Osteoporosis Growth Hormone Hyperactivity Disorder Testosterone Vascular Products Benign Prostatic Hyperplasia Bipolar Disorder Obsessive Compulsive Disorder Percutaneous Cardiovascular Products Mesothelioma Growth Hormone Deficiency Head And Neck Cancers Major Depressive Disorders Oncology Products Treatment Resistant Depression Bulimia Nervosa Erectile Dysfunction Mood Disorders Panic Disorder Percutaneous Coronary Intervention Psychology Respiratory And Other Diseases Testosterone Deficiency

Is LLY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 218.0
52 Week Low 129.21
Average Volume 2,950,827
200-Day Moving Average 169.62
50-Day Moving Average 189.35
20-Day Moving Average 189.60
10-Day Moving Average 193.01
Average True Range 3.49
ADX 15.87
+DI 25.78
-DI 20.36
Chandelier Exit (Long, 3 ATRs ) 186.79
Chandelier Exit (Short, 3 ATRs ) 189.06
Upper Bollinger Band 199.30
Lower Bollinger Band 179.90
Percent B (%b) 0.84
BandWidth 10.23
MACD Line 2.06
MACD Signal Line 0.99
MACD Histogram 1.0742
Fundamentals Value
Market Cap 187.69 Billion
Num Shares 957 Million
EPS 6.11
Price-to-Earnings (P/E) Ratio 32.10
Price-to-Sales 5.72
Price-to-Book 28.85
PEG Ratio 1.14
Dividend 2.96
Dividend Yield 1.51%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 199.74
Resistance 3 (R3) 199.70 198.48 199.15
Resistance 2 (R2) 198.48 197.59 198.50 198.95
Resistance 1 (R1) 197.35 197.03 197.92 197.39 198.76
Pivot Point 196.13 196.13 196.42 196.15 196.13
Support 1 (S1) 195.00 195.24 195.57 195.04 193.66
Support 2 (S2) 193.78 194.68 193.80 193.47
Support 3 (S3) 192.65 193.78 193.27
Support 4 (S4) 192.69